Pembrolizumab for Fanconi anemia with advanced tongue cancer
Introduction: With underlying Fanconi Anemia, head and neck cancer treatment options are usually limited due to the chromosome instability. Pembrolizumab plays a vital role in head and neck cancer with recurrence and distant metastases. However, the safety of pembrolizumab for Fanconi anemia patient...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | Otolaryngology Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246854882200039X |